Tasly Pharmaceutical Group Co., Ltd

Quick facts

Marketed products

• Active drug group
  This is a broad category descriptor rather than a specific drug, referring to any pharmaceutical compound with active therapeutic properties marketed by Tasly Pharmaceutical Group.

Phase 3 pipeline

• a simulated agent of Jitongning tablets · Cardiovascular
  Jitongning tablets are a simulated agent that works by inhibiting the renin-angiotensin-aldosterone system (RAAS) to lower blood pressure.
• Antiwei Granules · Oncology
  Antiwei Granules is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to support anti-tumor activity.
• Changkang granules · Gastroenterology
  Changkang granules is a traditional Chinese medicine formulation that promotes gastrointestinal motility and improves digestive function.
• Jitongning tablets · Pain Management / Traditional Chinese Medicine
  Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow.
• Lianxiaxiaopi Granules · Gastroenterology
  Lianxiaxiaopi Granules is a traditional Chinese medicine formulation that modulates gastrointestinal function and reduces inflammation to treat functional dyspepsia and related digestive disorders.
• Qingzhu Granules · Immunology/Inflammation
  Qingzhu Granules is a traditional Chinese medicine formulation that clears heat and resolves toxicity to treat heat-related inflammatory conditions.
• Susu Xiao'er Zhike Granules · Immunology
  Susu Xiao'er Zhike Granules is a traditional Chinese medicine formula that has been studied for its potential anti-inflammatory and immunomodulatory effects.

Phase 2 pipeline

• Changkang Granule · Gastroenterology
  Changkang Granule is a traditional Chinese medicine formulation that modulates gastrointestinal function and promotes intestinal health through multiple herbal components.
• HuHuangLianzonggan capsule
• Jia Shen Tablet
• JS1-1-01 high-dose group
• JS1-1-01 low-dose group
• Sanhuangjingshimingwan · Other

Phase 1 pipeline

• B2065
• Jiashen Tablets
• JS1-1-01
• Qishenyiqi dripping pills, 12 bags
• Qishenyiqi dripping pills, 6 bags
• Qishenyiqi dripping pills, 9 bags
• STRO-002

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Tasly Pharmaceutical Group Co., Ltd portfolio CI brief
• Tasly Pharmaceutical Group Co., Ltd pipeline updates RSS